Medicenna Therapeutics

$4.16
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.11 (+2.72%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell MDNA and other stocks, options, and ETFs commission-free!

About MDNA

Medicenna Therapeutics Corp. Common Shares, also called Medicenna Therapeutics, is a clinical stage immuno-oncology company which engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers. Read More The company was founded by Fahar Merchant and Rosemina Merchant on February 2, 2015 and is headquartered in Toronto, Canada. The listed name for MDNA is Medicenna Therapeutics Corp. Common Shares.

Employees
7
Headquarters
Toronto, Ontario
Founded
2015
Market Cap
203.20M
Price-Earnings Ratio
Dividend Yield
Average Volume
107.90K
High Today
$4.23
Low Today
$4.09
Open Price
$4.09
Volume
71.09K
52 Week High
$5.32
52 Week Low
$0.8835

Collections

You May Also Like